Deniz Bakkalci is a biotech investor and translational scientist focused on advancing breakthrough women’s health innovations. As Women’s Health Investment Lead at NG Bio, she sources and evaluates early-stage biopharma and med-tech opportunities, driving scientific and commercial diligence, portfolio strategy, and venture creation. She combines deep technical expertise from a PhD in tissue engineering at UCL with hands-on experience in oncology clinical trials and spatial biology R&D. Deniz builds strong partnerships across founders, academia, pharma, and investors to accelerate scalable solutions in areas long overlooked in medicine.